Showing results (1751-1760 of 2,155) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|November 22, 2017
Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patientsHojin Moon, Yuan Zhao, Dustin Pluta, et al.Journal of Biopharmaceutical Statistics|November 11, 2017
Penalty-based approaches to evaluating multiplicity adjustments in clinical trials: Advanced multiplicity problemsGautier Paux, Alex DmitrienkoJournal of Biopharmaceutical Statistics|February 9, 2018
Two-stage approach based on zone and dose findings for two-agent combination Phase I/II trialsFumiya Shimamura, Chikuma Hamada, Shigeyuki Matsui, et al.Journal of Biopharmaceutical Statistics|March 23, 2018
Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trialAndrea Ghiglietti, Maria Giovanna Scarale, Rosalba Miceli, et al.Journal of Biopharmaceutical Statistics|December 19, 2018
Comparison of balancing scores using the ANCOVA approach for estimating average treatment effect: a simulation studyChunhao Tu, Woon Yuen KohJournal of Biopharmaceutical Statistics|November 14, 2019
A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcomeIan R White, Royes Joseph, Nicky BestJournal of Biopharmaceutical Statistics|November 14, 2019
Group sequential design for historical control trials using error spending functionsJianrong Wu, Yimei LiJournal of Biopharmaceutical Statistics|November 30, 2019
ASIED: a Bayesian adaptive subgroup-identification enrichment designYanxun Xu, Florica Constantine, Yuan Yuan, et al.Journal of Biopharmaceutical Statistics|November 28, 2017
Parametric modeling and optimal experimental designs for estimating isobolograms for drug interactions in toxicologyTim Holland-Letz, Nikolas Gunkel, Eberhard Amtmann, et al.Journal of Biopharmaceutical Statistics|December 15, 2017
An enhanced mixture method for constructing gatekeeping procedures in clinical trialsGeorge Kordzakhia, Thomas Brechenmacher, Eiji Ishida, et al.Pageof 216